Allogeneic islet transplantation (Q36981652)

17 August 2017

1 reference

title

Allogeneic islet transplantation (English)

1 reference

17 August 2017

Simona Marzorati

1

0 references

Antonello Pileggi

object named as

Antonello Pileggi

series ordinal

2

0 references

Camillo Ricordi

object named as

Camillo Ricordi

series ordinal

3

0 references

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

11

1 reference

17 August 2017

page(s)

1627-1645

1 reference

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Successful islet transplantation: continued insulin reserve provides long-term glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Reduced fear of hypoglycemia in successful islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Five-year follow-up after clinical islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

International trial of the Edmonton protocol for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The cost-effectiveness of intensive therapy for diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The unique cytoarchitecture of human pancreatic islets has implications for islet cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Automated method for isolation of human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Rescue purification maximizes the use of human islet preparations for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Variables in organ donors that affect the recovery of human islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Improved human islet isolation using nicotinamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Modified two-layer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Pancreatic islet transplantation: the radiographic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Long-term graft function after allogeneic islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

{beta}-Cell function following human islet transplantation for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Quality of life after islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Insulin independence after islet transplantation into type I diabetic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

In vivo effect of FK506 on human pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Elevated portal vein drug levels of sirolimus and tacrolimus in islet transplant recipients: local immunosuppression or islet toxicity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The portal immunosuppressive storm: relevance to islet transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Lack of cytomegalovirus transmission after pancreatic islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Alterations of the female reproductive system in recipients of islet grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Resolution of severe atopic dermatitis after tacrolimus withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Rapamycin Has a Deleterious Effect on MIN-6 Cells and Rat and Human Islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Mycophenolate mofetil in islet cell transplant: variable pharmacokinetics but good correlation between total and unbound concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Immunosuppression for pancreatic islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Stable alpha- and beta-islet cell function after tolerance induction to pancreatic islet allografts in diabetic primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Long-term functional islet mass and metabolic function after xenoislet transplantation in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

FTY720, an immunomodulatory sphingolipid mimetic: translation of a novel mechanism into clinical benefit in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

CD28/B7 system of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Tolerance and pancreatic islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Islet transplantation: immunological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

An antagonist mutant IL-15/Fc promotes transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

New treatments for acute humoral rejection of kidney allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Cell migration, chimerism, and graft acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Multiple bone marrow infusions to enhance acceptance of allografts from the same donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Targeted bone marrow radioablation with 153Samarium-lexidronam promotes allogeneic hematopoietic chimerism and donor-specific immunologic hyporesponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Donor and isolation variables associated with human islet monocyte chemoattractant protein-1 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Culture medium modulates proinflammatory conditions of human pancreatic islets before transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

A functional CD40 receptor is expressed in pancreatic beta cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

IP-10 and type 1 diabetes: a question of time and location.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Protecting pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Short-term culture with the caspase inhibitor z-VAD.fmk reduces beta cell apoptosis in transplanted islets and improves the metabolic outcome of the graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Prolonged Allogeneic Islet Graft Survival by Protoporphyrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Adenoviral gene transfer of erythropoietin confers cytoprotection to isolated pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Inflammatory blockade improves human pancreatic islet function and viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Alpha1-antitrypsin protects beta-cells from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Pretransplant HLA antibodies are associated with reduced graft survival after clinical islet transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Survival and metabolic function of syngeneic rat islet grafts transplanted in the omental pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Stem-cell therapy for diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Stem cell plasticity and tissue replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Isolation of amniotic stem cell lines with potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Expansion of mesenchymal stem cells from human pancreatic ductal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Expansion and redifferentiation of adult human pancreatic islet cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Fresh human islet transplantation to replace pancreatic endocrine function in type 1 diabetic patients. Report of six cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Human islet allografts in patients with type 2 diabetes undergoing liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Experience with human islet transplantation in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhĵne Alpes Genève pour la transplantation d'Ilots de Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Selection of diabetic patients for islet transplantation. A single-center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

The clinical use of antilymphocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

Intracellular Stress Signaling Pathways Activated During Human Islet Preparation and Following Acute Cytokine Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.11.1627

10.1517/14712598.7.11.1627

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference